News Keytruda set for first line lung cancer use in EU MSD drug will not face competition from BMS rival in this use.
News Novartis’ COPD combo show benefits in switching from establi... A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to N
News NICE approval for Keytruda a 'milestone' in lung cancer But drug will not be funded for longer than two years.
News Early filing gives GSK a boost in COPD Compelling data from FULFIL study puts GSK in pole position
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.